Green and Intelligent Manufacturing Technology Upgrade Project for Pharmaceutical Active Ingredients and Intermediates at Zhejiang Guobang Pharmaceutical Co., Ltd

Thread Content

Project Name: Green and Intelligent Manufacturing Technology Upgrade Project for Pharmaceutical Active Ingredients and Intermediates by Zhejiang Guobang Pharmaceutical Co., Ltd.
Launch Date: April 7, 2026
Region: Zhejiang
Industry/Project Type: Chemicals and Pharmaceuticals/Pharmaceuticals/Chemical Active Ingredients
Project Owner: Zhejiang Guobang Pharmaceutical Co., Ltd.
Total Investment: 1,020 million yuan
Current Progress: Project registration completed
Construction Location: Wei Wu Road, Hangzhou Wanshangyu Economic and Technological Development Zone, Zhejiang Province
Construction Content: The project will enable annual production of 5 tons of landiolol hydrochloride (new), 10 tons of cinnacalcet hydrochloride (unchanged), 100 tons of vonoprazan fumarate (95 tons new), 250 tons of vildagliptin (140 tons new), 10 tons of cariprazine hydrochloride (new), 100 tons of glucosamine sulfate sodium chloride complex salt (new), 10 tons of efavirenz (new), 5 tons of apixaban (4 tons new), 10 tons of solifenacin succinate (unchanged), 600 tons of S1 (new), 800 tons of S3 (new), 520 tons of Z042 (unchanged), 338 tons of 7-ACF (unchanged), 3 tons of sacubitril hydrochloride (new), 8 tons of febuxostat (new), 6 tons of pramlintide (new), 2 tons of dapson (new), 30 tons of lanthanum carbonate (new), 50 tons of venlafaxine hydrochloride (new), 30 tons of aripiprazole (new), 2 tons of lumeperon tosylate (new), 50 tons of topiramate (new), 3 tons of remimazepam (new), 2 tons of bedaquiline fumarate (new), 3 tons of amornavir (new), 5 tons of baricitinib (new), 10 tons of ferrocoxib (new), 20 tons of fluralaner (new), 3 tons of prasugrel (new), 15 tons of benzothiophene fluorobenzene (new), 3 tons of 6(S)-acetoxytropinone (new), 1,300 tons of norfloxacin (900 tons new), 650 tons of sodium methanesulfate (new), 100 tons of darufloxacin mesylate (unchanged), 80 tons of tolterodine (50 tons new), 700 tons of KX (300 tons new), 2,000 tons of ciprofloxacin hydrochloride (800 tons new), 30 tons of cefpodoxime axetil (new), 400 tons of cefixime (200 tons new), 300 tons of cephalosporin C crude product (new), 700 tons of cefuroxime axetil (300 tons new)； Annually, 380 tons of potassium chloride, 1,132 tons of sodium sulfite, 1,525 tons of hydrochloric acid, 220 tons of potassium fluoroborate, 570 tons of methanol, 316 tons of triphenylphosphine oxide, 138 tons of thiolbenzothiazole, and 821 tons of sodium bromide are produced as by-products. Once the project reaches full capacity, it will generate an additional annual sales revenue of 2,879.5 million yuan, profits of 440 million yuan, and tax revenues of 230 million yuan. \The project will be implemented in two phases; the first phase requires an investment of 350 million yuan, during which the existing land at the company’s Plant No. 6 will be utilized, the current factory buildings will be demolished, and new workshops, administrative buildings, as well as other supporting facilities will be constructed ； The second-phase investment amounts to 670 million yuan; it involves making use of the existing land at the company’s plants No. 6, No. 8, and No. 22, demolishing the current factory buildings, and constructing new workshops, power facilities, as well as other supporting structures. Progress milestone: The project registration was completed in 2025, on 2026-04-03. (Project registration)